Objectives: Childhood abuse is a powerful prognostic indicator in adults with major depressive disorder (MDD) and is associated with numerous biological risk factors for depression. The purpose of this investigation was to explore if antidepressant medication affinity for the serotonin transporter moderates the association between childhood abuse and treatment response. Methods: Our sample included 52 outpatients with MDD who had received up to 26 weeks of pharmacotherapy, stratifying antidepressant medications with a high versus a low affinity for the serotonin transporter. Patients completed the Hamilton Rating Scale for Depression, Beck Depression Inventory II, Home Environment Questionnaire, and Ontario Health Supplement: Child Abuse and Trauma Scale to assess depression and childhood abuse. Results: Medication class moderated the link between 3 indices of childhood abuse and treatment response such that higher levels of childhood abuse were associated with higher levels of depression severity after treatment only in those patients receiving antidepressant medications with a weak affinity for the serotonin transporter. Conclusions: This pilot study suggested that prolonged exposure to stress during childhood may result in biological vulnerabilities for depression, which may in turn be differentially targeted by pharmacological agents which target serotonin to a greater or lesser degree.

Keywords:
Childhood abuse, Major depressive disorder, Neglect, Physical abuse, Serotonin, Treatment response
1.
Patten SB, Wang JL, Williams JV, et al: Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006;51:84-90.
2.
Harkness KL, Bagby RM, Kennedy SH: Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder. J Consult Clin Psychol 2012;80:342-353.
3.
Hyttel J: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994;9(suppl 1):19-26.
4.
Kim SW, Kang HJ, Kim SY, et al: Impact of childhood adversity on the course and suicidality of depressive disorders: the CRESCEND study. Depress Anxiety 2013;30:965-974.
5.
Caspi A, Sugden K, Moffitt TE, et al: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389.
6.
Hornung OP, Heim CM: Gene-environment interactions and intermediate phenotypes: early trauma and depression. Front Endocrinol 2014;5:14.
7.
Harkness KL, Strauss J, Bagby RM, Stewart JG, Larocque C, Mazurka R, Ravindran A, Wynne-Edwards KE, Rector NA, Kennedy J: Interactions between childhood maltreatment and brain-derived neurotrophic factor and serotonin transporter polymorphisms on depression symptoms. Psychiatry Res 2015;229:609-612.
8.
Heim C, Binder EB: Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 2012;233:102-111.
9.
Bousman CA, Gunn JM, Potiriadis M, Everall IP: Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: a 5-year prospective cohort study. World J Biol Psychiatry 2016, pp 1-7.
10.
Danese A, Moffitt TE, Harrington H, et al: Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 2009;163:1135-1143.
11.
Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J: SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev 2000;2:CD001851.
12.
Moncrieff J, Kirsch I: Efficacy of antidepressants in adults. BMJ 2005;331:155-157.
13.
Magni LR, Purgato M, Gastaldon C, et al: Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev 2013;7:CD004185.
14.
Nemeroff CB, Heim CM, Thase ME, et al: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA 2003;100:14293-14296.
15.
Asarnow JR, Emslie G, Clarke G, et al: Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009;48:330-339.
16.
Lewis CC, Simons AD, Nguyen LJ, et al: Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2010;49:132-140.
17.
Nanni V, Uher R, Danese A: Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry 2012;169:141-151.
18.
Della Femina D, Yeager CA, Lewis DO: Child abuse: adolescent records vs. adult recall. Child Abuse Negl 1990;14:227-231.
19.
Kennedy SH, Eisfeld BS, Meyer JH, Bagby RM: Antidepressants in clinical practice: limitations of assessment methods and drug response. Hum Psychopharmacol 2001;16:105-114.
20.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
21.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
22.
Sines JO, Clarke WM, Lauer RM: Home environment questionnaire. J Abnorm Child Psychol 1984;12:519-529.
23.
Gibb BE, Chelminski I, Zimmerman M: Childhood emotional, physical, and sexual abuse, and diagnoses of depressive and anxiety disorders in adult psychiatric outpatients. Depress Anxiety 2007;24:256-263.
24.
MacMillan HL, Fleming JE, Trocme N, et al: Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA 1997;278:131-135.
25.
Gross AB, Keller HR: Long-term consequences of childhood physical and psychological maltreatment. Aggressive Behavior 1992;18:171-185.
26.
Henkel V, Seemuller F, Obermeier M, et al: Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord 2009;115:439-449.
27.
Blier P, Saint-Andre E, Hebert C, de Montigny C, Lavoie N, Debonnel G: Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropsychopharmacol 2007;10:41-50.
28.
Singh AB, Bousman CA, Ng CH, Byron K, Berk M: Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study. Clin Psychopharmacol Neurosci 2015;13:53-61.
29.
Brown GW, Craig TK, Harris TO, Handley RV, Harvey AL: Validity of retrospective measures of early maltreatment and depressive episodes using the Childhood Experience of Care and Abuse instrument - a life-course study of adult chronic depression - 2. J Affect Disord 2007;103:217-224.
30.
Khan A, McCormack HC, Bolger EA, et al: Childhood maltreatment, depression, and suicidal ideation: critical importance of parental and peer emotional abuse during developmental sensitive periods in males and females. Front Psychiatry 2015;6:42.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.